In fact, the ability of SARS-CoV-2 to downregulate the host IFN-I response is considered a viral strategy of immune evasion [24], and early expression of INF-α in patients with COVID-19 is associated with a lower risk of progression to severe forms [25]. Here, IFNA17 is linked to COVID-19.